Interleukin Genetics, Inc. (ILI) Executive ManagementBoard of Directors, and all of our employees, are committed to the highest ethical standards and to conducting business with the highest level of integrity. We are dedicated to sound corporate governance practices to serve the long-term interests of our shareholders. Interleukin’s Code of Business Conduct and Ethics forms the foundation upon which our reputation as a respected industry leader is built. Interleukin’s management practices demand accountability and abide by the codes set forth in the Sarbanes-Oxley Act of 2002, as well as other Corporate Governance regulations. These values drive our behavior as we aspire to earn and keep the trust and respect of our shareholders, customers and employees.